Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway - PubMed (original) (raw)

Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway

W Lou et al. Prostate. 2000.

Abstract

Background: Interleukin-6 (IL-6) is a pleiotropic cytokine that regulates growth and differentiation of various types of malignant tumors, including prostate carcinomas. The levels of IL-6 are elevated in sera of patients with metastatic prostate cancer. In this study, we evaluate the role of IL-6 in the growth regulation of prostate cancer cells.

Methods: Expression of IL-6 and its receptors in human prostate cancer cells was measured by ELISA and RT-PCR. The effects of IL-6 on cell growth were evaluated by ectopically expressing IL-6 cDNA into IL-6-negative LNCaP human prostate cancer cells. Stat3 DNA binding activities were analyzed by electromobility shift assay and supershift assay.

Results: Expression of IL-6 was detected in the androgen-insensitive prostate cancer cell lines (i.e. , TSU, PC3, and DU145), but not in the androgen-sensitive LNCaP cell line. IL-6 receptors, including both IL-6-specific receptor alpha chain and gp130 signal transducer, are expressed in all human prostate cancer cell lines (i.e., LNCaP, TSU, PC3, and DU145). Overexpression of IL-6 by ectopically expressing IL-6 into IL-6-negative LNCaP human prostate cancer cells significantly increased clonogenic ability and cell proliferation in vitro compared to the IL-6-negative parental LNCaP cells and the antisense controls. This growth stimulation by IL-6 was accompanied by activation of the Stat3 signaling transduction pathway.

Conclusions: IL-6 is an autocrine growth factor for LNCaP human prostate cancer cells; the effects of IL-6 on prostate cancer cell growth are mediated through the Janus kinase-signal transducers and activators of transcription (JAK-STAT) signaling pathway.

PubMed Disclaimer

Cited by

mRNA Levels of Aromatase, 5α-Reductase Isozymes, and Prostate Cancer-Related Genes in Plucked Hair from Young Men with Androgenic Alopecia.
Sánchez P, Serrano Falcón C, Martínez Rodríguez S, Torres JM, Serrano S, Ortega E. Sánchez P, et al. Int J Mol Sci. 2023 Dec 14;24(24):17461. doi: 10.3390/ijms242417461. Int J Mol Sci. 2023. PMID: 38139289 Free PMC article.
TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells.
Moreira D, Zhang Q, Hossain DM, Nechaev S, Li H, Kowolik CM, D'Apuzzo M, Forman S, Jones J, Pal SK, Kortylewski M. Moreira D, et al. Oncotarget. 2015 Jul 10;6(19):17302-13. doi: 10.18632/oncotarget.4029. Oncotarget. 2015. PMID: 26046794 Free PMC article.
NANOG Dominates Interleukin-6-Induced Sphere Formation in Prostate Cancer.
Seven D, Tecimel D, Bayrak ÖF. Seven D, et al. Urol Res Pract. 2023 Nov;49(6):376-380. doi: 10.5152/tud.2023.23116. Urol Res Pract. 2023. PMID: 37987305 Free PMC article.
IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK/STAT signalling pathway in human bladder cancer.
Huang W, Li Y, Zhang C, Zha H, Zhou X, Fu B, Guo J, Wang G. Huang W, et al. J Cell Mol Med. 2020 Dec;24(23):13949-13960. doi: 10.1111/jcmm.16003. Epub 2020 Oct 22. J Cell Mol Med. 2020. PMID: 33094561 Free PMC article.
Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.
Deeble PD, Murphy DJ, Parsons SJ, Cox ME. Deeble PD, et al. Mol Cell Biol. 2001 Dec;21(24):8471-82. doi: 10.1128/MCB.21.24.8471-8482.2001. Mol Cell Biol. 2001. PMID: 11713282 Free PMC article.

Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway - PubMed (original) (raw)